AUNA

Auna SA

Auna SA (AUNA) is rated C+ (2.7/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (B); its weakest is Growth (C-). The rating has held at C+ for 6 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.7 / 5.0
C+
Value
C+
Factor Score 2.6 / 5.0
Growth
C-
Factor Score 2.0 / 5.0
Profitability
B
Factor Score 3.2 / 5.0
Momentum
B-
Factor Score 3.0 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 77.2
EV / EBITDA 4.8
Rev Growth YoY 13.2%
Gross Margin 36.9%
Price Return 3M -14.6%
Price Return 12M -6.5%
Catalyst Signal 0.00
Market Cap $342.9M
TTM Revenue $4.7B
Price / Sales 0.1
ROE 1.6%

Historical Factor Score Progression

Held C+ for 6 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-17 C+ (2.6) C- (2.0) B (3.2) B- (3.0) C+ (2.6) C+ (2.7)
2026-11-10 C+ (2.6) C- (2.0) B (3.2) C+ (2.8) C+ (2.6) C+ (2.6)
2026-11-03 C+ (2.6) C- (2.0) B (3.2) C+ (2.7) C+ (2.7) C+ (2.6)
2026-10-27 C+ (2.5) C- (2.0) B (3.2) C+ (2.5) C+ (2.6) C+ (2.6)
2026-10-20 C (2.5) C- (2.0) B (3.2) C+ (2.6) C+ (2.6) C+ (2.6)
Page 1 of 4